Prior to a cannabinoid topical product being sold or transferred to a consumer, patient or designated primary caregiver the container holding the cannabinoid product must have a label that has the following information:

1. (1) Processor’s business or trade name and license number;
2. (2) Business or trade name of licensee that packaged the product, if different from the processor;
3. (3) UID number;
4. (4) Product identity;
5. (5) Date the product was made;
6. (6) Net weight or volume in U.S. customary and metric units;
7. (7) Amount suggested for use by the consumer or patient at any one time;
8. (8) Concentration of THC and CBD in the container (%);
9. (9) List of ingredients in descending order of predominance by weight or volume used to process the cannabinoid topical;
10. (10) Name of the lab that performed any test and any test analysis date;
11. (11) Universal symbol;
12. (12) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

13. (13) For cannabinoid topicals for sale to a consumer, warnings that state:

    1. (a) “For use only by adults 21 and older. Keep out of reach of children.”
    2. (b) “DO NOT EAT” in bold, capital letters.

Statutory/Other Authority

ORS 475C.604

Statutes/Other Implemented

ORS 475C.604

History

OLCC 150-2022, minor correction filed 03/25/2022, effective 03/25/2022
OLCC 6-2018, adopt filed 05/23/2018, effective 06/01/2018